Financial statements Lycopharm
Balance sheet of Lycopharm
Company age:
Age:
4 y. 8 m. 8 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of LYCOPHARM
|
Year
|
2021
|
2022
|
2023
|
2024
|
|---|---|---|---|---|
| Total assets | 8 426 612,06 | 13 425 841,90 | 10 829 002,20 | 7 906 239,79 |
| A. Fixed assets | 7 418 835,16 | 10 655 341,81 | 9 084 585,67 | 6 785 088,16 |
| B. Current assets | 1 007 776,90 | 2 770 500,09 | 1 744 416,53 | 1 121 151,63 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 8 426 612,06 | 13 425 841,90 | 10 829 002,20 | 7 906 239,79 |
| A. Equity | 7 118 256,97 | 6 437 754,94 | 555 262,97 | -6 304 160,06 |
| B. Liabilities and provisions for liabilities | 1 308 355,09 | 6 988 086,96 | 10 273 739,23 | 14 210 399,85 |
| I. Long-term liabilities | - | 3 163 207,36 | 9 606 578,60 | 13 566 866,70 |
| II. Short-term liabilities | - | 3 824 879,60 | 643 805,83 | 620 443,68 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.